Caribou Biosciences has launched a Phase 1 trial testing its CAR T-cell therapy CB-010 for lupus affecting the kidneys and ...

The Phase 1 GALLOP study evaluating the investigational therapy, CB-010, for treatment of lupus nephritis has launched.

To achieve the goals set out in its ‘Vision 2030’, argenx has set the following priorities for 2025: VYVGART ® (IV: efgartigimod alfa-fcab and SC: efgartigimod alfa and hyaluronidase-qvfc) is a ...

Table 2. Results from randomized controlled trials comparing mycophenolate mofetil versus azathioprine for maintenance therapy in proliferative (class III–IV) lupus nephritis. AZA (120 mg/day ...

Objective Traditional initial treatment regimens for lupus nephritis (LN) used oral glucocorticoids (GC) in starting doses up to 1.0 mg/kg/day prednisone equivalent with or without a preceding ...

DEAR DR. ROACH: I am a 77-year-old female. After experiencing hair thinning for over a year, I was diagnosed with incomplete lupus by a rheumatologist. My blood markers were high, but I don’t ...

This is a MedPage Today story. In late September, Hurricane Helene damaged a major supplier of intravenous (IV) fluids. In this report, we follow up on what has happened since. Hurricane Helene ...